[Pathological characteristics of patients with diabetes mellitus type 2, in Spanish Primary Care]

Rev Clin Esp. 2004 Jan;204(1):18-24. doi: 10.1157/13056787.
[Article in Spanish]


Context: To know the characteristics, related risk factors, and degree of control in patients with diabetes mellitus type 2 (DM2) in our country.

Methods: Observational, unrandom, opened, and multicenter study. Anthropometric characteristics, substance abuse, medication, control of diabetes, cholesterol, and triglycerides were analyzed in 5,395 patients. The patients were classified according to the length of the diagnosis: recent diabetes (RD) and known diabetes (KD). The chi-square test was utilized in order to compare the categorical variables, and the Student's t test for compare the continuous variables. The relationship between these variables was analyzed through the Pearson's correlation coefficient, and an analysis of multiple correspondence was carried out.

Results: Median age, 63 years; obese, 34%; smokers, 11%; drinkers, 24%; hypertensives, 44%; lipemic, 42%. Control degree: HbA1c>6.5% in 79%, LDLc>115 mg/dl in 80%. Hypoglycemic treatment: sulfonylureas, 62.8%; antidiabetics combination, 5%; only insulin, 4.3%; insulin combined with antidiabetics, 20.6%. Control of diabetics, of lipids, and of weight was lower in the patients with KD that in the patients with RD (HbA1c, 7.6% versus 7%; LDLc 148 mg/dl versus 136 mg/dl; percentage of obese, 27.2% versus 38.62%). A relationship between the length of evolution of diabetes and the deterioration of the control of blood glucose and of lipids was detected.

Conclusion: DM2 and its associated risk factors are insufficiently controlled in our country. The drug combination and insulin are utilized scarcely.

Publication types

  • Comparative Study
  • English Abstract
  • Multicenter Study

MeSH terms

  • Anthropometry
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / therapy
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Lipids / blood*
  • Male
  • Middle Aged
  • Risk Factors
  • Spain / epidemiology


  • Blood Glucose
  • Hypoglycemic Agents
  • Lipids